2024 - News Updates
-
The latest Cancer Currents: An NCI Cancer Research Blog post features DCEG researchers, Drs. Ruth Pfeiffer and Peter Kraft, who discuss how breast cancer risk assessment tools are created and how people can use them to understand and manage their risk.
-
In June, the 2024 Society for Epidemiologic Research (SER) Annual Meeting in Austin, Texas was attended by DCEG scientists. Caroline Pruitt, postbaccalaureate fellow in the Occupational and Environmental Epidemiology Branch, received the Kathy Rose Travel Scholarship, sponsored by SER and DLH Holdings Corporation.
-
Genetic counselors in the Clinical Genetics Branch, Megan Frone, M.S., C.G.C., and Jessica Hatton, M.S., C.G.C., were recognized with 2024 Significant Contributor Awards by ClinGen, a National Institutes of Health (NIH)-funded resource dedicated to building an authoritative central resource that defines the clinical relevance of genes and variants for use in precision medicine and research.
-
The latest NCI Media Advisory featured research led by Erikka Loftfield, investigator in the Metabolic Epidemiology Branch (MEB), which showed that daily multivitamin use was not associated with lower risk of death.
-
The Connect for Cancer Prevention Study is a new prospective cohort seeking to enroll 200,000 adults in the United States. Connect is designed to further investigate the etiology of cancer and its outcomes, which may inform new approaches in precision prevention and early detection. We will update the research community as to the progress of Connect across multiple topics of interest.
-
Prospective cohort studies have informed our understanding of cancer, directing scientific inquiries in basic and clinical laboratory science, as well as translational studies and treatment trials, and led to the development of guidelines and regulatory actions to protect public health. Learn about the different DCEG cohort studies based in the United States and the major accomplishments they have achieved to date.
-
Lawrence “Larry” Ingrassia talked about the evolution of his book, "A Fatal Inheritance: How a Family Misfortune Revealed a Medical Mystery," and his engagement with LFS researchers, including Dr. Joseph F. Fraumeni, Jr. The seminar at the National Cancer Institute drew an audience full of leading researchers in cancer epidemiology and genetics.
-
Dr. Fiona Malcomson has joined DCEG as part of the first cohort of the Cancer Research Transatlantic Development and Skills Enhancement (DSE) Award.
-
NCI Media Advisory features DCEG research which identified inherited genetic variants that may predict loss of X chromosome in older women (mLOX).
-
An NCI Cancer Currents blog post on advances in anal cancer screening features DCEG researchers in the Infections and Immunoepidemiology and Clinical Genetics Branches.
-
In age-period-cohort modeling of SEER data, researchers led by Philip Rosenberg in the Biostatistics Branch projected that Generation X will experience larger per-capita increases in the incidence of leading cancers combined than any prior generation.
-
Dr. Jill Barnholtz-Sloan is CBIIT’s new acting director following Dr. Tony Kerlavage’s retirement. In addition to this role, Dr. Barnholtz-Sloan maintains her responsibility as associate director for the Informatics and Data Science Program and senior investigator in the Division of Cancer Epidemiology and Genetics, Trans-Divisional Research Program.
-
In June 2024, Mitchell Machiela was awarded scientific tenure by the NIH and promoted to senior investigator in the Integrative Tumor Epidemiology Branch. He is an internationally recognized expert on the genetic architecture of cancer and genetic mosaicism.
-
Three projects were funded. Two support data processing for the Pediatric Proton and Photon Therapy Comparison Cohort. The third will facilitate the development and evaluation of polygenic risk scores across diverse populations.
-
In June 2024, Lisa McReynolds was appointed Lasker Clinical Research Scholar, a tenure-track position in the Clinical Genetics Branch. She is an expert in hematopoiesis, bone marrow failure, and predisposition to myeloid malignancies.
-
Jacqueline B. Vo has been promoted to the role of tenure-track investigator in the Radiation Epidemiology Branch (REB). In 2022, she was the first nurse at the NCI appointed to the role of assistant clinical investigator, also in REB.
-
Dr. Vo was interviewed for the NIH IRP Podcast, Speaking of Science, where she discussed dismantling the myth of Asian American, Native Hawaiian, and Other Pacific Islander populations as a monolith.
-
Jazmyn Bess, Patricia Erickson, Wayne Lawrence, Deborah Tadesse, and Sonam Tulsyan gave interviews to the Inside Cancer Careers Podcast host Oliver Bogler live at the 2024 American Association for Cancer Research (AACR) Annual Meeting in San Diego, California. They shared their science, career path, and thoughts on attending the AACR annual meeting.
-
On May 17th at the Shady Grove Campus, the NCI hosted the first Think Tank on Advancing Gastric Cancer Prevention, a forum for a multidisciplinary group of gastric cancer experts to review the state of the science and collaboratively identify critical knowledge gaps.
-
In the NCI-Kaiser Permanente Breast Cancer Survivors Cohort, DCEG experts observed increased risk of cardiovascular disease that breast cancer survivors treated with anthracyclines and/or trastuzumab that persisted 10+ years after diagnosis and was heightened for women diagnosed before age 65, compared to women who did not receive chemotherapy.